• The Lead Podcast - Episode 73

  • Aug 8 2024
  • Length: 19 mins
  • Podcast

The Lead Podcast - Episode 73

Listen for free

View show details

  • Summary

  • William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Rod S. Passman, MD, FHRS, Northwestern University and Graham Peigh, MD, MS, Northwestern Memorial Hospital to discuss the direct oral anticoagulants (DOACs) reduce stroke risk in patients with device-detected atrial fibrillation (DD-AFib) but increase major bleeding risk. The time to benefit (TTB) and time to harm (TTH) are not well quantified.

    https://www.hrsonline.org/education/TheLead
    https://www.heartrhythmjournal.com/article/S1547-5271(24)02812-1/fulltext#secsectitle0055


    Host Disclosure(s):
    W. Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, Research: Medtronic

    Contributor Disclosure(s):
    G. Peigh: Nothing to disclose
    R. Passman: Research: AHA Foundation Award, Abbott Medical, NIH/NHLBI, Apple Inc., Royalty Income: UpToDate, Inc, Honoraria/Speaking/Consulting: Janssen Pharmaceuticals, Boston Scientific, Membership on Advisory Committees: Medtronic, iRhythm Technologies


    This episode has .25 ACE credits associated with it. If you want credit for listening to this episode, please visit the episode page on HRS365 https://www.heartrhythm365.org/URL/TheLeadEpisode73
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
activate_samplebutton_t1

What listeners say about The Lead Podcast - Episode 73

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available